Kitze B - Search Results

1

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Helwig A, Poser S. Rieckmann P, et al. Among authors: kitze b. Ann Neurol. 1995 Jan;37(1):82-8. doi: 10.1002/ana.410370115. Ann Neurol. 1995. PMID: 7818262

2

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.

Yushchenko M, Mäder M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F. Yushchenko M, et al. Among authors: kitze b. J Neurol. 2003 Oct;250(10):1224-8. doi: 10.1007/s00415-003-0191-4. J Neurol. 2003. PMID: 14586607 Clinical Trial.

3

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.

Rieckmann P, Martin S, Weichselbraun I, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Helwig A, et al. Rieckmann P, et al. Among authors: kitze b. Neurology. 1994 Dec;44(12):2367-72. doi: 10.1212/wnl.44.12.2367. Neurology. 1994. PMID: 7527508 Clinical Trial.

4

A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases.

Puccioni-Sohler M, Rieckmann P, Kitze B, Lange P, Albrecht M, Felgenhauer K. Puccioni-Sohler M, et al. Among authors: kitze b. J Neurol. 1995 Mar;242(4):239-42. doi: 10.1007/BF00919597. J Neurol. 1995. PMID: 7798123

5

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis.

Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Poser S. Rieckmann P, et al. Among authors: kitze b. Neurology. 1994 Aug;44(8):1523-6. doi: 10.1212/wnl.44.8.1523. Neurology. 1994. PMID: 8058164

6

Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis.

Rieckmann P, Weber F, Günther A, Martin S, Bitsch A, Broocks A, Kitze B, Weber T, Börner T, Poser S. Rieckmann P, et al. Among authors: kitze b. J Neuroimmunol. 1996 Feb;64(2):193-200. doi: 10.1016/0165-5728(95)00176-x. J Neuroimmunol. 1996. PMID: 8632062 Clinical Trial.

7

Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.

Bitsch A, Dressel A, Meier K, Bogumil T, Deisenhammer F, Tumani H, Kitze B, Poser S, Weber F. Bitsch A, et al. Among authors: kitze b. J Neurol. 2004 Dec;251(12):1498-501. doi: 10.1007/s00415-004-0580-3. J Neurol. 2004. PMID: 15645350 Clinical Trial.

8

Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients.

Kitze B, Turner RW, Burchhardt M, Poser S, Hunsmann G, Weber T. Kitze B, et al. Clin Investig. 1992 Nov;70(11):1013-8. doi: 10.1007/BF00180311. Clin Investig. 1992. PMID: 1361867

9

No evidence of Borna disease virus-specific antibodies in multiple sclerosis patients in Germany.

Kitze B, Herzog S, Rieckmann P, Poser S, Richt J. Kitze B, et al. J Neurol. 1996 Sep;243(9):660-2. doi: 10.1007/BF00878664. J Neurol. 1996. PMID: 8892069 No abstract available.

10

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b.

Brettschneider J, Ecker D, Bitsch A, Bahner D, Bogumil T, Dressel A, Elitok E, Kitze B, Poser S, Weber F, Tumani H. Brettschneider J, et al. Among authors: kitze b. J Neuroimmunol. 2002 Dec;133(1-2):193-7. doi: 10.1016/s0165-5728(02)00353-3. J Neuroimmunol. 2002. PMID: 12446022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters